Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Antiherpesvirus agent from Roche

March 13, 1997

Antifungal agents from Nihon Nohyaku

March 13, 1997

GS-4104 enters human testing

March 12, 1997

SKB's Vectavir introduced in Germany

March 12, 1997

Genome Therapeutics and Versicor collaborate on new antibacterial compounds

March 12, 1997

New antibacterial agents from Daiichi

March 12, 1997

Antibacterial agent isolated by Sanwa Kagaku

March 12, 1997

Sankyo prepares antifungal agents

March 11, 1997

Synsorb sponsors research on carbohydrate synthesis

March 10, 1997

New antifungal agents from Lilly

March 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...